All News

Thomas Geelhaar, Head of Chemicals R&D at Merck in Darmstadt, Germany, describes how the company scouts for technologies and interacts with universities.

ITI Life Sciences, Scotland’s publicly funded innovation group, is to invest a further £2 million in its programme to develop new drug discovery tools.

Europe’s fastest civil supercomputer, Jugene, was inaugurated by North Rhine-Westphalia Prime Minister Jürgen Rüttgers at the Jülich Research Centre last week.

A record 156,000 patents were filed under the Patent Cooperation Treaty in 2007, up 4.7 per cent over the previous year.

The UK biotech sector has fallen victim to the mayhem in the capital markets. After a year of falling share prices, five quoted companies have put up “for sale” signs.

Scotland launched the latest version of its strategy to become one of world’s top locations for life sciences by 2020, as the hopes vested in two of its leading research companies Stem Cell Sciences and Ardana Biosciences, turned to dust.

The UK Medical Research Council has appointed Dave Tapolczay as head of its technology transfer company, MRC Technology.